Brightening Cream and Lasers in Post-sclerotherapy Hyperpigmentation

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

March 3, 2022

Primary Completion Date

January 14, 2025

Study Completion Date

January 14, 2025

Conditions
HyperpigmentationVaricosis
Interventions
DEVICE

QS Nd:YAG laser

Patients will be treated with Quality-switched (QS) Neodymium-doped yttrium aluminum garnet (Nd:YAG) laser (MedLite® C6) operating at a wavelength of 1064 nm, fluence range from 2.1 J/cm2 to 8.1 J/cm2 with a 4-6mm spot size.

DRUG

Triple cream

Patients will be treated with a triple brightening cream (Pigmanorm®), applied daily, three times per week for 12 weeks on the lesion. Interruption for 4 days will be adopted in case of irritation/redness. 50+ sun protection cream will be used as well during the treatment period.

Trial Locations (1)

3010

Department of dermatology, University Hospital Inselspital, Bern, Bern

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER